{
  "trial_id": "NCT01923363",
  "trial_group": "obesity",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, BMI, Weight, Gender, Central line access, Language (English or Spanish), Hepatic function, Seizure history, Hematologic history, Pregnancy status, Allergy history to beta-lactams or tazobactam.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Body Mass Index (BMI)",
          "BMI"
        ],
        [
          "Weight",
          "Weight"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Total Bilirubin",
        "ICU Status",
        "Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II Score",
        "Sequential Organ Failure Assessment (SOFA) Score"
      ],
      "remaining_candidate_features": [
        "Gender",
        "Central line access",
        "Language (English or Spanish)",
        "Hepatic function",
        "Seizure history",
        "Hematologic history",
        "Pregnancy status",
        "Allergy history to beta-lactams or tazobactam."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Weight, Hepatic Function (Child-Pugh Classification), Seizure Disorder History, Hematologic Disorder History, Pregnancy Status, Allergy or Contraindication to Beta-lactams or Tazobactam, Central Line Access,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "Weight",
          "Weight"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Total Bilirubin",
        "ICU Status",
        "Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II Score",
        "Sequential Organ Failure Assessment (SOFA) Score"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Hepatic Function (Child-Pugh Classification)",
        "Seizure Disorder History",
        "Hematologic Disorder History",
        "Pregnancy Status",
        "Allergy or Contraindication to Beta-lactams or Tazobactam",
        "Central Line Access"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, BMI, Weight, Region of Enrollment, Language, Central Line Access, Hepatic Impairment, Seizure Disorder, Hematologic Disorder, Pregnancy, Allergy to Beta-lactams or Tazobactam.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Mass Index (BMI)",
          "BMI"
        ],
        [
          "Weight",
          "Weight"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Total Bilirubin",
        "ICU Status",
        "Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II Score",
        "Sequential Organ Failure Assessment (SOFA) Score"
      ],
      "remaining_candidate_features": [
        "Language",
        "Central Line Access",
        "Hepatic Impairment",
        "Seizure Disorder",
        "Hematologic Disorder",
        "Pregnancy",
        "Allergy to Beta-lactams or Tazobactam."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, weight, BMI, height, ethnicity, language, presence of central line access, presence of suspected or confirmed infection(s), medical history (hepatic impairment, seizure disorder, hematologic disorder), pregnancy status, allergy status to beta-lactams or tazobactam.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index (BMI)",
          "BMI"
        ],
        [
          "Weight",
          "weight"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Total Bilirubin",
        "ICU Status",
        "Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II Score",
        "Sequential Organ Failure Assessment (SOFA) Score"
      ],
      "remaining_candidate_features": [
        "height",
        "ethnicity",
        "language",
        "presence of central line access",
        "presence of suspected or confirmed infection(s)",
        "medical history (hepatic impairment, seizure disorder, hematologic disorder)",
        "pregnancy status",
        "allergy status to beta-lactams or tazobactam."
      ]
    }
  }
}